Being an academic is a vocation. We are not in it for the money (hopefully), but mostly (hopefully) for the impact that we can make on our students’ and colleagues’ lives, as well as to contribute to the process of healthy law and policy-making. It is a job with lots of responsibility, joys, surprises and … Read more
Wir appellieren an Sie: Frau Ministerin Brandes, ziehen Sie den Gesetzentwurf zurück! Verfassungsrechtlerinnen und Verfassungsrechtler aus allen juristischen Fakultäten des Landes NRW haben sich zu der folgenden Stellungnahme zusammengeschlossen. Sie trägt die Unterschrift einer deutlichen Mehrzahl aller aktiven Hochschullehrer des Verfassungsrechts, mehrere Rechtsfakultäten sind mit ihrem Öffentlichen Recht vollständig vertreten. __ Wir lehren und … Read more
For better or worse, cheap business insurance may be the first way business owners look to reduce or cut costs. But, great coverage will protect you from even more financial harm. Getting the right business insurance — without breaking the bank — can be a big challenge for small business owners like you. But skipping … Read more
Introduction It’s beginning to look a lot like Christmas at Focus! This month, we’ve embraced the festive spirit with Christmas Jumper Day – bringing out our best (and worst!) jumpers to support an amazing cause. From reindeers to snowmen and a few bold fashion choices in between, it’s all been for Save the Children. As we … Read more
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 FLASH2 Trial of HyBryte in CTCL is Underway On December 16, 2024, Soligenix, Inc. (NASDAQ:SNGX) announced that patient enrollment has opened up for the confirmatory Phase 3 FLASH2 (Fluorescent Light Activated Synthetic Hypericin 2) trial of HyBryte in patients with … Read more
